Molecular Tug-of-war Reveals New Insights into Disease Origins and Potential Treatments
A newly discovered interplay between proteins within cells could revolutionize our understanding of diseases ranging from cancer to neurodegenerative disorders, according to a study led by researchers at Penn State. The findings, focused on the regulation of mRNA – the molecules carrying genetic blueprints – suggest a surprisingly complex system where opposing forces maintain cellular balance.
Researchers have long known that mRNA delivers instructions for building proteins, the workhorses of cells. Once these instructions are delivered, a protein complex called CCR4-NOT clears out the mRNA. However, the team’s research, detailed in an upcoming issue of the Journal of Biological Chemistry, reveals that CCR4-NOT doesn’t operate as a unified team. Instead, different proteins within the complex have opposing roles: one destabilizes mRNA, while the other stabilizes it.
the breakthrough came through experimentation in human colorectal cancer cells, utilizing a novel tool to temporarily disable specific proteins. By removing CNOT1, a key component of CCR4-NOT, the researchers observed a slowdown in mRNA removal. Conversely, eliminating CNOT4 accelerated the clean-up process.
“Traditionally, subunits are expected to work together toward a common function, but our results show that CNOT1 and CNOT4 are engaged in a tug-of-war over mRNA stability,” said Sachin Kulkarni, assistant professor of molecular biology at Penn State and lead author of the study. “This delicate balance is crucial for proper cellular function, and when the regulatory system fails, it can lead to diseases such as cancer, developmental disorders or metabolic problems.”
The research centers on CCR4-NOT, described as a “molecular machine” that regulates the entire lifecycle of RNA. This lifecycle includes the transcription of instructions from DNA to mRNA, the processing and packaging of mRNA, and ultimately, the breakdown of RNA. The final step – RNA degradation – is primarily governed by CCR4-NOT.
First discovered in yeast in the early 1990s, CCR4-NOT is present in nearly all eukaryotic cells – the cells that comprise animals, plants, fungi, and many other organisms. While extensively studied in yeast, its role in human cells remained less understood. To address this gap, the Penn State team developed the auxin-inducible degron (AID) system, a tool that allows scientists to rapidly and reversibly “switch off” specific proteins within a cell.
“by being able to quickly destroy proteins of interest, the AID system allows precise control over protein levels in human cells, letting us observe what happens when a specific protein is temporarily removed,” Kulkarni said.
Using the AID system on the DLD-1 colorectal cancer cell line, researchers were able to deplete either CNOT1 or CNOT4 within 60 minutes. Depleting CNOT1 altered thousands of transcripts and slowed mRNA decay,while depleting CNOT4 had little affect on transcripts but accelerated mRNA degradation.
“Understanding the intricacies of the opposing effects CNOT1 and CNOT4 have on mRNA stability has several implications,” Kulkarni explained. “Such knowledge could help identify disease contexts in which either subunit is dysregulated, inform the growth of biomarkers based on characteristic mRNA decay patterns and provide insights for therapeutic strategies that target mRNA stability and fine-tune gene regulation.”
The research team included Courtney Smith and Oluwasegun T. Akinniyi, graduate students at Penn State, alongside belinda M. Giardine, programmer/analyst, and Cheryl A. Keller, research professor and director of the Penn State Genomics Core Facility. alexei Arnaoutov of the National Institutes of Health also contributed to the work. The study was supported by core facilities at the Huck Institutes of the Life Sciences at Penn State, including the Huck Proteomics and Mass Spectrometry Core Facility, the Genomics Core Facility, the Flow Cytometry Core facility, and the Genomics Research Incubator.
The research was funded by the National Institutes of Health (NIH). With their new system, the researchers have opened the door to further exploration of the complex mechanisms governing gene regulation and its impact on human health.
